Immunogen reported $-27369000 in EBIT for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebit Change
Acceleron Pharma XLRN:US $ -63662000 59K
Agios Pharmaceuticals AGIO:US $ -91222000 5K
Amgen AMGN:US $ 2333M 204M
Arena Pharmaceuticals ARNA:US $ -144391000 12.4M
Astellas Pharma 4503:JP 35.8B 59.96B
AstraZeneca AZN:LN 1.4B 366M
Bluebird Bio BLUE:US $ -240791000 9.95M
Bristol Myers Squibb BMY:US $ 2967M 411M
Cerulean Pharma CERU:US $ -9162930 1.47M
Dicerna Pharmaceuticals DRNA:US $ -40244000 11.14M
Eli Lilly And LLY:US $ 1428.4M 237.8M
Emergent Biosolutions EBS:US $ 14.5M 80.9M
Exelixis EXEL:US $ 123.01M 127.62M
Halozyme Therapeutics HALO:US $ 93.05M 42.31M
Heron Therapeutics HRTX:US $ -60469000 8.36M
Immunogen IMGN:US $ -27369000 1.55M
Karyopharm Therapeutics KPTI:US $ -49048000 3.32M
Macrogenics MGNX:US $ -40279000 11.01M
Nektar Therapeutics NKTR:US $ -110205000 813K
Novartis NVS:US 3.4B 415M
Pfizer PFE:US $ 6662M 905M
Regeneron Pharmaceuticals REGN:US $ 3347.2M 2234.5M
Seattle Genetics SGEN:US $ -89603000 32.82M